Fierce Biotech

1. Artiva, fresh from Merck pact, raises $120M for NK therapy R&D 

   Artiva, fresh from Merck pact, raises $120M for NK therapy R&D  ntaylor Fri, 02/26/2021 - 08:39

2. Genentech teams with academics for 10-year neuroscience R&D push

   Genentech teams with academics for 10-year neuroscience R&D push ntaylor Fri, 02/26/2021 - 07:51

3. Oncolytics Bio's cancer-killing virus arms CAR-T cells to attack solid tumors in mice

   Oncolytics Bio's cancer-killing virus arms CAR-T cells to attack solid tumors in mice aliu Fri, 02/26/2021 - 07:30

4. Chutes & Ladders—Moderna CMO hits exit amid COVID-19 vaccine rollout

   Chutes & Ladders—Moderna CMO hits exit amid COVID-19 vaccine rollout fkansteiner Fri, 02/26/2021 - 07:18

5. FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back

   FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back badams Fri, 02/26/2021 - 03:47